Hippocampal neurogenesis in Alzheimer's disease: Is there a role for dietary modulation?

Journal of Alzheimer's Disease

Volumn 38, Issue 1, 2014, Pages 11-38

  Maruszak, Aleksandra ^a   Pilarski, Adam ^a   Murphy, Tytus ^a   Branch, Nicholas ^a   Thuret, Sandrine ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; calorie restriction; diet; fatty acids; folate; neurogenesis; nutrients; polyphenols; thiamine; zinc

Indexed keywords

ALCOHOL; BILOBALIDE; BLUEBERRY EXTRACT; CAFFEINE; CARBOHYDRATE; CURCUMIN; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FAT; FATTY ACID; FLAVONOID; FOLIC ACID; GINKGO BILOBA EXTRACT; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; POLYPHENOL; POLYUNSATURATED FATTY ACID; QUERCETIN; RESVERATROL; SATURATED FATTY ACID; THIAMINE; ZINC;

ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; BLUEBERRY; CALORIC RESTRICTION; CLINICAL ASSESSMENT; COFFEE; COGNITIVE DEFECT; DEMENTIA; DIET; DRUG BIOAVAILABILITY; GINKGO BILOBA; HIPPOCAMPUS; HUMAN; KETOGENIC DIET; LIPID DIET; MOTOR DYSFUNCTION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; VITAMIN SUPPLEMENTATION;

ALZHEIMER'S DISEASE; CALORIE RESTRICTION; DIET; FATTY ACIDS; FOLATE; NEUROGENESIS; NUTRIENTS; POLYPHENOLS; THIAMINE; ZINC;

ALZHEIMER DISEASE; CALORIC RESTRICTION; DIET; HIPPOCAMPUS; HUMANS; NEUROGENESIS;

EID: 84887223751     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131004     Document Type: Review

References (217)

1. Wortmann M (2012) Dementia: A global health priority-highlights from an ADI and World Health Organization report. Alzheimers Res Ther 4, 40.
2. Debette S, Wolf PA, Beiser A, Au R, Himali JJ, Pikula A, Auerbach S, Decarli C, Seshadri S (2009) Association of parental dementia with cognitive and brain MRI measures in middle-aged adults. Neurology 73, 2071-2078.
3. Holtzman DM, Mandelkow E, Selkoe DJ (2012) Alzheimer disease in 2020. Cold Spring Harb Perspect Med 2, pii: a011585.
4. Braak H, Braak E, Bohl J (1993) Staging of Alzheimer-related cortical destruction. Eur Neurol 33, 403-408. (Pubitemid 23358066)
5. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH (1998) Neurogenesis in the adult human hippocampus. Nat Med 4, 1313-1317. (Pubitemid 28512114)
6. Zainuddin MSA, Thuret S (2012) Nutrition, adult hippocam-pal neurogenesis and mental health. Br Med Bull 103, 89-114.
7. Aimone JB, Wiles J, Gage FH (2006) Potential role for adult neurogenesis in the encoding of time in new memories. Nat Neurosci 9, 723-727.
8. Shors TJ, Miesegaes G, Beylin A, Zhao M, Rydel T, Gould E (2001) Neurogenesisin the adultis involvedinthe formation of trace memories. Nature 410, 372-376. (Pubitemid 32246054)
9. Shors TJ, Townsend DA, Zhao M, Kozorovitskiy Y, Gould E (2002) Neurogenesis may relate to some but not all types of hippocampal-dependent learning. Hippocampus 12, 578-584. (Pubitemid 35363952)
10. Kuhn HG, Dickinson-Anson H, Gage FH (1996) Neuro-genesis in the dentate gyrus of the adult rat: Age-related decrease of neuronal progenitor proliferation. J Neurosci 16, 2027-2033. (Pubitemid 26144015)
11. Knoth R, Singec I, Ditter M, Pantazis G, Capetian P, Meyer RP, Horvat V, Volk B, Kempermann G (2010) Murine features of neurogenesis in the human hippocampus across the lifespan from 0 to 100 years. PLoS One 5, e8809.
12. Mu Y, Gage FH (2011) Adult hippocampal neurogenesis and its role in Alzheimer's disease. Mol Neurodegener 6, 85.
13. Lazarov O, Marr RA (2010) Neurogenesis and Alzheimer's disease: At the crossroads. Exp Neurol 223, 267-281.
14. Choi SH, Veeraraghavalu K, Lazarov O, Marler S, Ransohoff RM, Ramirez JM, Sisodia SS (2008) Non-cell-autonomous effects of presenilin 1 variants on enrichment-mediated hippocampal progenitor cell proliferation and differentiation. Neuron 59, 568-580.
15. Burbach GJ, Hellweg R, Haas CA, Del Turco D, Deicke U, Abramowski D, Jucker M, Staufenbiel M, Deller T (2004) Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice. J Neurosci 24, 2421-2430. (Pubitemid 38327955)
16. Nakamura S, Arima K, Haga S, Aizawa T, Motoi Y, Otsuka M, Ueki A, Ikeda K (1998) Fibroblast growth factor (FGF)-9 immunoreactivityinsenile plaques. Brain Res814, 222-225. (Pubitemid 29023431)
17. Tarkowski E, Issa R, Sjogren M, Wallin A, Blennow K, Tarkowski A, Kumar P (2002) Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol Aging 23, 237-243. (Pubitemid 34137098)
18. Monje ML, Toda H, Palmer TD (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302, 1760-1765. (Pubitemid 37505739)
19. Ziv Y, Schwartz M (2008) Orchestrating brain-cell renewal: The role of immune cells in adult neurogenesis in health and disease. Trends Mol Med 14, 471-478.
20. Biscaro B, Lindvall O, Tesco G, Ekdahl CT, Nitsch RM (2012) Inhibition of microglial activation protects hip-pocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's disease. Neu-rodegener Dis 9, 187-198.
21. Boekhoorn K, Joels M, Lucassen PJ (2006) Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus. Neurobiol Dis 24, 1-14. (Pubitemid 44416208)
22. Jin K, Peel AL, Mao XO, Xie L, Cottrell BA, Henshall DC, Greenberg DA (2004) Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci USA 101, 343-347. (Pubitemid 38084252)
23. Perry EK, Johnson M, Ekonomou A, Perry RH, Ballard C, Attems J (2012) Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly relatedto cholinergic pathology. Neurobiol Dis 47, 155-162.
24. Verret L, Jankowsky JL, Xu GM, Borchelt DR, Rampon C (2007) Alzheimer's-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis. J Neurosci 27, 6771-6780. (Pubitemid 46983445)
25. Rodriguez JJ, Verkhratsky A (2011) Neurogenesis in Alzheimer's disease. J Anat 219, 78-89.
26. Gould E, Tanapat P, Rydel T, Hastings N (2000) Regulation of hippocampal neurogenesis in adulthood. Biol Psychiatry 48, 715-720.
27. Lopez-Toledano MA, Ali Faghihi M, Patel NS, Wahlestedt C (2010) Adult neurogenesis:A potential tool for early diagnosis in Alzheimer's disease? J Alzheimers Dis 20, 395-408.
28. Zheng M, Liu J, Ruan Z, Tian S, Ma Y, Zhu J, Li G (2013) Intrahippocampal injection of Abeta (1-42) inhibits neuro-genesis and down-regulates IFN-gamma and NF-kappaB expression in hippocampus of adult mouse brain. Amyloid 20, 13-20.
29. Dias GP, Cavegn N, Nix A, do Nascimento Bevilaqua MC, Stangl D, Zainuddin MS, Nardi AE, Gardino PF, Thuret S (2012) The role of dietary polyphenols on adult hippocam-pal neurogenesis: Molecular mechanisms and behavioural effects on depression and anxiety. Oxid Med Cell Longev 2012, 541971.
30. Luchsinger JA, Mayeux R (2004) Dietary factors and Alzheimer's disease. Lancet Neurol 3, 579-587. (Pubitemid 39221925)
31. Stangl D, Thuret S (2009) Impact of diet on adult hippocam-pal neurogenesis. Genes Nutr 4, 271-282.
32. Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, Pilotto A (2011) Diet and Alzheimer's disease risk factors or prevention: The current evidence. Expert Rev Neurother 11, 677-708.
33. Witte AV, Fobker M, Gellner R, Knecht S, Floel A (2009) Caloric restriction improves memory in elderly humans. Proc Natl Acad Sci USA 106, 1255-1260.
34. Luchsinger JA, Tang MX, Shea S, Mayeux R (2002) Caloric intake and the risk of Alzheimer disease. Arch Neurol 59, 1258-1263. (Pubitemid 34856378)
35. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I (2003) An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 163, 1524-1528. (Pubitemid 36835095)
36. Wu P, Shen Q, Dong S, Xu Z, Tsien JZ, Hu Y (2008) Calorie restriction ameliorates neurodegenerative phenotypes in forebrain-specific presenilin-1 and presenilin-2 double knockout mice. Neurobiol Aging 29, 1502-1511.
37. Wang J, Ho L, Qin W, Rocher AB, Seror I, Humala N, Maniar K, Dolios G, Wang R, Hof PR, Pasinetti GM (2005) Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J 19, 659-661. (Pubitemid 40471277)
38. Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, Zhao W, Thiyagarajan M, MacGrogan D, Rodgers JT, Puigserver P, Sadoshima J, Deng H, Pedrini S, Gandy S, Sauve AA, Pasinetti GM (2006) Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281, 21745-21754. (Pubitemid 44181878)
39. Halagappa VK, Guo Z, Pearson M, Matsuoka Y, Cutler RG, Laferla FM, Mattson MP (2007) Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse modelofAlzheimer's disease. Neurobiol Dis 26, 212-220. (Pubitemid 46436499)
40. Patel NV, Gordon MN, Connor KE, Good RA, Engel-man RW, Mason J, Morgan DG, Morgan TE, Finch CE (2005) Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models. Neurobiol Aging 26, 995-1000. (Pubitemid 40312661)
41. Qin W, Chachich M, Lane M, Roth G, Bryant M, de Cabo R, Ottinger MA, Mattison J, Ingram D, Gandy S, Pasinetti GM (2006) Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus). J Alzheimers Dis 10, 417-422.
42. Srivastava S, Haigis MC (2011) Role of sirtuins and calorie restriction in neuroprotection: Implications in Alzheimer's and Parkinson's diseases. Curr Pharm Des 17, 3418-3433.
43. Lee J, Duan W, Mattson MP (2002) Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neu-rogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem 82, 1367-1375.
44. Bondolfi L, Ermini F, Long JM, Ingram DK, Jucker M (2004) Impact of age and caloric restriction on neurogen-esis in the dentate gyrus of C57BL/6 mice. Neurobiol Aging 25, 333-340. (Pubitemid 38220969)
45. Lee J, Duan W, Long JM, Ingram DK, Mattson MP (2000) Dietary restriction increases the number of newly generated neural cells, and induces BDNF expression, in the dentate gyrus of rats. J Mol Neurosci 15, 99-108. (Pubitemid 32108679)
46. Diniz BS, Teixeira AL (2011) Brain-derived neurotrophic factor and Alzheimer's disease: Physiopathology and beyond. Neuromolecular Med 13, 217-222.
47. Michan S, Li Y, Chou MM, Parrella E, Ge H, Long JM, Allard JS, Lewis K, Miller M, Xu W, Mervis RF, Chen J, Guerin KI, Smith LE, McBurney MW, Sinclair DA, Baudry M, de Cabo R, Longo VD (2010) SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci 30, 9695-9707.
48. Vedin I, Cederholm T, Freund-Levi Y, Basun H, Garlind A, Irving GF, Eriksdotter-Jonhagen M, Wahlund LO, Dahlman I, Palmblad J (2012) Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: The OmegAD study. PLoS One 7, e35425.
49. Codocedo JF, Allard C, Godoy JA, Varela-Nallar L, Ine-strosa NC (2012) SIRT1 regulates dendritic development in hippocampal neurons. PLoS ONE 7, e47073.
50. Chen J, Zhou Y, Mueller-Steiner S, Chen LF, Kwon H, Yi S, Mucke L, Gan L (2005) SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem 280, 40364-40374. (Pubitemid 41779174)
51. Kanoski SE, Davidson TL (2011) Western diet consumption and cognitive impairment: Links to hippocampal dysfunction and obesity. Physiol Behav 103, 59-68.
52. Laitinen MH, Ngandu T, Rovio S, Helkala EL, Uusitalo U, Viitanen M, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M (2006) Fat intakeat midlife and risk ofdementia and Alzheimer's disease: A population-based study. Dement Geriatr Cogn Disord 22, 99-107.
53. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, Schneider J, Wilson RS (2003) Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 60, 194-200. (Pubitemid 36193962)
54. Hwang IK, Kim IY, Kim DW, Yoo KY, Kim YN, Yi SS, Won MH, Lee IS, Yoon YS, Seong JK (2008) Strain-specific differences in cell proliferation and differentiation in the dentate gyrus of C57BL/6N and C3H/HeN mice fed a high fat diet. Brain Res 1241, 1-6.
55. Jacob RA (1999) Evidence that diet modification reduces in vivo oxidant damage. Nutr Rev 57, 255-258. (Pubitemid 29473437)
56. Park HR, Park M, Choi J, Park KY, Chung HY, Lee J (2010) A high-fat diet impairs neurogenesis: Involvement of lipid peroxidation and brain-derived neurotrophic factor. Neurosci Lett 482, 235-239.
57. Tozuka Y, Wada E, Wada K (2009) Diet-induced obesity in female mice leads to peroxidized lipid accumulations and impairment of hippocampal neurogenesis during the early life of their offspring. FASEB J 23, 1920-1934.
58. Lindqvist A, Mohapel P, Bouter B, Frielingsdorf H, Pizzo D, Brundin P, Erlanson-Albertsson C (2006) High-fat diet impairs hippocampal neurogenesis in male rats. Eur J Neu-rol 13, 1385-1388. (Pubitemid 44736653)
59. Maesako M, Uemura K, Kubota M, Kuzuya A, Sasaki K, Hayashida N, Asada-Utsugi M, Watanabe K, Uemura M, Kihara T, Takahashi R, Shimohama S, Kinoshita A (2012) Exercise is more effective than diet control in preventing high fat diet-induced beta-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice. J Biol Chem 287, 23024-23033.
60. Zhang W, Li P, Hu X, Zhang F, Chen J, Gao Y (2011) Omega-3 polyunsaturated fatty acids in the brain: Metabolism and neuroprotection. Front Biosci 16, 2653-2670.
61. Su HM (2010) Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance. J Nutr Biochem 21, 364-373.
62. Cunnane SC, Chouinard-Watkins R, Castellano CA, Barberger-Gateau P (2013) Docosahexaenoic acid home-ostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence? Prostaglandins Leukot Essent Fatty Acids 88, 61-70.
63. Bhatia HS, Agrawal R, Sharma S, Huo YX, Ying Z, Gomez-Pinilla F (2011) Omega-3 fatty acid deficiency during brain maturation reduces neuronal and behavioral plasticity in adulthood. PLoS One 6, e28451.
64. Kawakita E, Hashimoto M, Shido O (2006) Docosahex-aenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 139, 991-997.
65. Katakura M, Hashimoto M, Okui T, Shahdat HM, Matsuzaki K, Shido O (2013) Omega-3 polyunsaturated Fatty acids enhance neuronal differentiation in cultured rat neural stem cells. Stem Cells Int 2013, 490476.
66. Sydenham E, Dangour AD, Lim WS (2012) Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev 6, CD005379.
67. Broersen LM, Kuipers AA, Balvers M, van Wijk N, Savelk-oul PJ, deWilde MC, van der Beek EM, Sijben JW, Hageman RJ, Kamphuis PJ, Kiliaan AJ (2013) A specific multi-nutrient diet reduces Alzheimer-like pathology in young adult AbetaPPswe/PS1dE9 mice. J Alzheimers Dis 33, 177-190.
68. Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M, Shinto L, Aisen PS (2010) Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial. JAMA 304, 1903-1911.
69. Freund-Levi Y, Hjorth E, Lindberg C, Cederholm T, Faxen-Irving G, Vedin I, Palmblad J, Wahlund LO, Schultzberg M, Basun H, Eriksdotter Jonhagen M (2009) Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: The OmegAD study. Dement Geriatr Cogn Disord 27, 481-490.
70. Freund-Levi Y, Basun H, Cederholm T, Faxen-Irving G, Garlind A, Grut M, Vedin I, Palmblad J, Wahlund LO, Eriksdotter-Jonhagen M (2008) Omega-3 supplementation in mild to moderate Alzheimer's disease: Effects on neuropsychiatric symptoms. Int J Geriatr Psychiatry 23, 161-169. (Pubitemid 351308496)
71. Barberger-Gateau P, Lambert JC, Feart C, Peres K, Ritchie K, Dartigues JF, Alperovitch A (2013) From genetics to dietetics: The contribution of epidemiology to understanding Alzheimer's disease. J Alzheimers Dis 33 (Suppl 1), S457-S463.
72. Kariv-Inbal Z, Yacobson S, Berkecz R, Peter M, Janaky T, Lutjohann D, Broersen LM, Hartmann T, Michaelson DM (2012) The isoform-specific pathological effectsofapoE4in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol. J Alzheimers Dis 28, 667-683.
73. Valente T, Hidalgo J, Bolea I, Ramirez B, Angles N, Reguant J, Morello JR, Gutierrez C, Boada M, Unzeta M (2009) A diet enrichedinpolyphenols and polyunsaturated fattyacids, LMN diet, induces neurogenesis in the subventricular zone and hippocampus of adult mouse brain. J Alzheimers Dis 18, 849-865.
74. Fernandez-Fernandez L, Comes G, Bolea I, Valente T, Ruiz J, Murtra P, Ramirez B, Angles N, Reguant J, Morello JR, Boada M, Hidalgo J, Escorihuela RM, Unzeta M (2012) LMN diet, rich in polyphenols and polyunsaturated fatty acids, improves mouse cognitive decline associated with aging and Alzheimer's disease. Behav Brain Res 228, 261-271.
75. Stafstrom CE, Rho JM (2012) The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmaco 3, 59.
76. Maalouf MA, Rho JM, Mattson MP (2009) The neuropro-tective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev 59, 293-315.
77. Strandberg J, Kondziella D, Thorlin T, Asztely F (2008) Ketogenic diet does not disturb neurogenesis in the dentate gyrus in rats. Neuroreport 19, 1235-1237.
78. Kwon YS, Jeong SW, Kim DW, Choi ES, Son BK (2008) Effects of the ketogenic diet on neurogenesis after kainic acid-induced seizures in mice. Epilepsy Res 78, 186-194.
79. Zilberter M, Ivanov A, Ziyatdinova S, Mukhtarov M, Malkov A, Alpar A, Tortoriello G, Botting CH, Fulop L, Osypov AA, Pitkanen A, Tanila H, Harkany T, Zilberter Y (2013) Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease. J Neurochem 125, 157-171.
80. Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costan-tiniLC (2009) Studyofthe ketogenic agent AC-1202inmild to moderate Alzheimer's disease: A randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond) 6, 31.
81. Kashiwaya Y, Bergman C, Lee JH, Wan R, King MT, Mughal MR, Okun E, Clarke K, Mattson MP, Veech RL (2013) A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease. Neurobiol Aging 34, 1530-1539.
82. Blaylock RL, Maroon J (2012) Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system. Surg Neurol Int 3, 19.
83. Beking K, Vieira A (2010) Flavonoid intake and disability-adjusted life years due toAlzheimer's and related dementias: A population-based study involving twenty-three developed countries. Public Health Nutr 13, 1403-1409.
84. Commenges D, Scotet V, Renaud S, Jacqmin-Gadda H, Barberger-Gateau P, Dartigues JF (2000) Intake of flavonoids and risk of dementia. Eur J Epidemiol 16, 357-363. (Pubitemid 30648741)
85. Hirohata M, Hasegawa K, Tsutsumi-Yasuhara S, Ohhashi Y, Ookoshi T, Ono K, Yamada M, Naiki H (2007) The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitroby preferential and reversible binding offlavonoidstothe amyloidfibril structure. Biochemistry46, 1888-1899.
86. Rezai-Zadeh K, Douglas Shytle R, Bai Y, Tian J, Hou H, Mori T, Zeng J, Obregon D, Town T, Tan J (2009) Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease beta-amyloid production. J Cell Mol Med 13, 574-588.
87. Onozuka H, Nakajima A, Matsuzaki K, Shin RW, Ogino K, Saigusa D, Tetsu N, Yokosuka A, Sashida Y, Mimaki Y, Yamakuni T, Ohizumi Y (2008) Nobiletin, acitrusflavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease. J Pharmacol Exp Ther 326, 739-744.
88. Vauzour D (2012) Dietary polyphenols as modulators of brain functions: Biological actions and molecular mechanisms underpinning their beneficial effects. Oxid Med Cell Longev 2012, 914273.
89. Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, Lucin KM, Czirr E, Park JS, Couillard-Despres S, Aigner L, Li G, Peskind ER, Kaye JA, Quinn JF, Galasko DR, Xie XS, Rando TA, Wyss-Coray T (2011) The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477, 90-94.
90. Ishrat T, Hoda MN, Khan MB, Yousuf S, Ahmad M, Khan MM, Ahmad A, Islam F (2009) Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT). Eur Neu-ropsychopharmacol 19, 636-647.
91. Dong S, Zeng Q, Mitchell ES, Xiu J, Duan Y, Li C, Tiwari JK, Hu Y, Cao X, Zhao Z (2012) Curcumin enhances neurogenesis and cognition in aged rats: Implications for transcriptional interactions related to growth and synaptic plasticity. PLoS One 7, e31211.
92. Mathew A, Fukuda T, Nagaoka Y, Hasumura T, Morimoto H, Yoshida Y, Maekawa T, Venugopal K, Kumar DS (2012) Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease. PLoS One 7, e32616.
93. Zhang L, Fiala M, Cashman J, Sayre J, Espinosa A, Maha-nian M, Zaghi J, Badmaev V, Graves MC, Bernard G, Rosenthal M (2006) Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. J Alzheimers Dis 10, 1-7. (Pubitemid 44401358)
94. Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ (2007) Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102, 1095-1104. (Pubitemid 47174225)
95. Park SY, Kim HS, Cho EK, Kwon BY, Phark S, Hwang KW, Sul D (2008) Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibitionof oxidative damage and tau hyperphosphorylation. Food Chem Toxicol 46, 2881-2887.
96. Ray B, Bisht S, Maitra A, Maitra A, Lahiri DK (2011) Neu-roprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc) in the neuronal cell culture and animal model: Implications for Alzheimer's disease. J Alzheimers Dis 23, 61-77.
97. Xu Y, Ku B, Cui L, Li X, Barish PA, Foster TC, Ogle WO (2007) Curcumin reverses impaired hippocampal neu-rogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res 1162, 9-18. (Pubitemid 47088372)
98. Kim SJ, Son TG, Park HR, Park M, Kim MS, Kim HS, Chung HY, Mattson MP, Lee J (2008) Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus. J Biol Chem 283, 14497-14505.
99. Wang Y, Yin H, Wang L, Shuboy A, Lou J, Han B, Zhang X, Li J (2013) Curcumin as a potential treatment for Alzheimer's disease: A study of the effects of curcumin on hippocampal expression of glial fibrillary acidic protein. Am J Chin Med 41, 59-70.
100. Reuter S, Gupta SC, Park B, Goel A, Aggarwal BB (2011) Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr 6, 93-108.
101. Kang SK, Cha SH, Jeon HG (2006) Curcumin-induced his-tone hypoacetylation enhances caspase-3-dependent glioma cell death and neurogenesis of neural progenitor cells. Stem Cells Dev 15, 165-174.
102. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I (2010) Regulation of SIRT1 in cellular functions: Role of polyphenols. Arch Biochem Biophys 501, 79-90.
103. Yoo KY, Choi JH, Hwang IK, Lee CH, Lee SO, Han SM, Shin HC, Kang IJ, Won MH (2010) (-)-Epigallocatechin-3-gallate increases cell proliferation and neuroblasts in the subgranular zone of the dentate gyrus in adult mice. Phy-tother Res 24, 1065-1070.
104. Burgos-Moron E, Calderon-Montano JM, Salvador J, Rob-les A, Lopez-Lazaro M (2010) The dark side of curcumin. Int J Cancer 126, 1771-1775.
105. Aisen PS, Cummings J, Schneider LS (2012) Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease. Cold Spring Harb Perspect Med 2, a006395.
106. Mancuso C, Siciliano R, Barone E, Preziosi P (2012) Natural substances and Alzheimer's disease: From preclinical studies to evidence based medicine. Biochim Biophys Acta 1822, 616-624.
107. Vellas B, Coley N, Ousset PJ, Berrut G, Dartigues JF, Dubois B, Grandjean H, Pasquier F, Piette F, Robert P, Touchon. J, Garnier P, Mathiex-Fortunet H, Andrieu S (2012) Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): A randomised placebo-controlled trial. Lancet Neurol 11, 851-859.
108. Amieva H, Meillon C, Helmer C, Barberger-Gateau P, Dartigues JF (2013) Ginkgo biloba extract and long-term cognitive decline: A 20-year follow-up population-based study. PLoS One 8, e52755.
109. Tchantchou F, Lacor PN, Cao Z, Lao L, Hou Y, Cui C, Klein WL, Luo Y (2009) Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common final pathway in hippocampal neurons. J Alzheimers Dis 18, 787-798.
110. Tchantchou F, Xu Y, Wu Y, Christen Y, Luo Y (2007) EGb 761 enhances adult hippocampalneurogenesis andphospho-rylationofCREB intransgenic mouse model of Alzheimer's disease. FASEB J 21, 2400-2408. (Pubitemid 47230670)
111. Kao TK, Ou YC, Raung SL, Lai CY, Liao SL, Chen CJ (2010) Inhibition of nitric oxide production by quercetin in endotoxin/cytokine-stimulated microglia. Life Sci 86, 315-321.
112. Yoo DY, Nam Y, Kim W, Yoo KY, Park J, Lee CH, Choi JH, Yoon YS, Kim DW, Won MH, Hwang IK (2011) Effects of Ginkgo biloba extract on promotion of neurogenesis in the hippocampal dentate gyrus in C57BL/6 mice. J Vet Med Sci 73, 71-76.
113. Joseph JA, Denisova NA, Arendash G, Gordon M, Diamond D, Shukitt-Hale B, Morgan D (2003) Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci 6, 153-162. (Pubitemid 36656693)
114. Casadesus G, Shukitt-Hale B, Stellwagen HM, Zhu X, Lee HG, Smith MA, Joseph JA (2004) Modulation of hippocam-pal plasticity and cognitive behaviorbyshort-term blueberry supplementation in aged rats. Nutr Neurosci 7, 309-316. (Pubitemid 40123781)
115. Williams CM, El Mohsen MA, Vauzour D, Rendeiro C, Butler LT, Ellis JA, Whiteman M, Spencer JP (2008) Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic Biol Med 45, 295-305.
116. Zhu Y, Bickford PC, Sanberg P, Giunta B, Tan J (2008) Blueberry opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activation protein kinase. Rejuvenation Res 11, 891-901.
117. Krikorian R, Shidler MD, Nash TA, Kalt W, Vinqvist-Tymchuk MR, Shukitt-Hale B, Joseph JA (2010) Blueberry supplementation improves memory in older adults. J Agric Food Chem 58, 3996-4000.
118. Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J (2006) Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience 142, 941-952. (Pubitemid 44740473)
119. Arendash GW, Jensen MT, Salem N, Hussein N Jr, Cracchi-olo J, Dickson A, Leighty R, Potter H (2007) A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Neuroscience 149, 286-302. (Pubitemid 47576542)
120. Cao C, Wang L, Lin X, Mamcarz M, Zhang C, Bai G, Nong J, Sussman S, Arendash G (2011) Caffeine synergizes with another coffee component to increase plasma GCSF: Linkage to cognitive benefits in Alzheimer's mice. J Alzheimers Dis 25, 323-335.
121. Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, Laage R, Aronowski J, Maurer MH, Gassler N, Mier W, Hasselblatt M, Kollmar R, Schwab S, Sommer C, Bach A, Kuhn HG, Schabitz WR (2005) The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 115, 2083-2098. (Pubitemid 41134150)
122. Laske C, Stellos K, Stransky E, Leyhe T, Gawaz M (2009) Decreased plasma levels of granulocyte-colony stimulating factor (G-CSF) in patients with early Alzheimer's disease. J Alzheimers Dis 17, 115-123.
123. Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Kary-das A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL, Tabaton M, Tinklenberg J, Yesavage JA, Tibshi-rani R, Wyss-Coray T (2007) Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 13, 1359-1362. (Pubitemid 350073592)
124. Swardfager W, Lanctot K, Rothenburg L, Wong A, Cap-pell J, Herrmann N (2010) A meta-analysis of cytokines in Alzheimer's disease. Biol Psychiatry 68, 930-941.
125. Cao C, Cirrito JR, Lin X, Wang L, Verges DK, Dickson A, Mamcarz M, Zhang C, Mori T, Arendash GW, Holtzman DM, Potter H (2009) Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice. J Alzheimers Dis 17, 681-697.
126. Cao C, Loewenstein DA, Lin X, Zhang C, Wang L, Duara R, Wu Y, Giannini A, Bai G, Cai J, Greig M, Schofield E, Ashok R, Small B, Potter H, Arendash GW (2012) High Blood caffeine levels in MCI linked to lack of progression to dementia. J Alzheimers Dis 30, 559-572.
127. Han ME, Park KH, Baek SY, Kim BS, Kim JB, Kim HJ, Oh SO (2007) Inhibitory effects of caffeine on hippocampal neurogenesis and function. Biochem Biophys Res Commun 356, 976-980.
128. Wentz CT, Magavi SS (2009) Caffeine alters proliferation of neuronal precursors in the adult hippocampus. Neurophar-macology 56, 994-1000.
129. Li F, Gong Q, Dong H, Shi J (2012) Resveratrol, a neuro-protective supplement for Alzheimer's disease. Curr Pharm Des 18, 27-33.
130. Granzotto A, Zatta P (2011) Resveratrol acts not through anti-aggregative pathways but mainly via its scavenging properties against Abeta and Abeta-metal complexes tox-icity. PLoS One 6, e21565.
131. Capiralla H, Vingtdeux V, Zhao H, Sankowski R, Al-Abed Y, Davies P, Marambaud P (2012) Resveratrol mitigates lipopolysaccharide-and Abeta-mediated microglial inflammation by inhibiting the TLR4/NF-kappaB/STAT signaling cascade. J Neurochem 120, 461-472.
132. Moriya J, Chen R, Yamakawa J, Sasaki K, Ishigaki Y, Taka-hashi T (2011) Resveratrol improves hippocampal atrophy in chronic fatigue mice by enhancing neurogenesis and inhibiting apoptosis of granular cells. Biol Pharm Bull 34, 354-359.
133. Harada N, Zhao J, Kurihara H, Nakagata N, Okajima K (2011) Resveratrol improves cognitive function in mice by increasing production of insulin-like growth factor-I in the hippocampus. J Nutr Biochem 22, 1150-1159.
134. Porquet D, Casadesus G, Bayod S, Vicente A, Canudas AM, Vilaplana J, Pelegri C, Sanfeliu C, Camins A, Pallas M, Del Valle J (2012) Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8. Age (Dordr), doi: 10. 1007/s11357-012-9489-4
135. Lourida I, Soni M, Thompson-Coon J, Purandare N, Lang IA, Ukoumunne OC, Llewellyn DJ (2013) Mediterranean diet, cognitive function, and dementia: A systematic review. Epidemiology 24, 479-489.
136. Kamphuis PJ, Scheltens P (2010) Can nutrients prevent or delay onset of Alzheimer's disease? J Alzheimers Dis 20, 765-775.
137. Lee JY, Cho E, Seo JW, Hwang JJ, Koh JY (2012) Alteration of the cerebral zinc pool in a mouse model of Alzheimer disease. J Neuropathol Exp Neurol 71, 211-222.
138. Azman MS, Wan Saudi WS, Ilhami M, Mutalib MS, Rahman MT (2009) Zinc intake during pregnancy increases the proliferation at ventricular zone of the newborn brain. Nutr Neurosci 12, 9-12.
139. Wang FD, Bian W, Kong LW, Zhao FJ, Guo JS, Jing NH (2001) Maternal zinc deficiency impairs brain nestin expression in prenatal and postnatal mice. Cell Res 11, 135-141. (Pubitemid 33677219)
140. Suh SW, Won SJ, Hamby AM, Yoo BH, Fan Y, Sheline CT, Tamano H, Takeda A, Liu J (2009) Decreased brain zinc availability reduces hippocampal neurogenesis in mice and rats. J Cereb Blood Flow Metab 29, 1579-1588.
141. Levenson CW, Morris D (2011) Zinc and neurogenesis: Making new neurons from development to adulthood. Adv Nutr 2, 96-100.
142. Corona C, Masciopinto F, Silvestri E, Viscovo AD, Lat-tanzio R, Sorda RL, Ciavardelli D, Goglia F, Piantelli M, Canzoniero LM, Sensi SL (2010) Dietary zinc supplemen-tationof3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction. Cell Death Dis 1, e91.
143. Loef M, von Stillfried N, Walach H (2012) Zinc diet and Alzheimer's disease: A systematic review. Nutr Neurosci 15, 2-12.
144. Roberts BR, Ryan TM, Bush AI, Masters CL, Duce JA (2012) The role of metallobiology and amyloid-beta pep-tides in Alzheimer's disease. J Neurochem 120 (Suppl 1), 149-166.
145. Linkous DH, Adlard PA, Wanschura PB, Conko KM, Flinn JM (2009) The effects of enhanced zinc on spatial memory and plaque formation in transgenic mice. J Alzheimers Dis 18, 565-579.
146. Wang H, Odegaard A, Thyagarajan B, Hayes J, Cruz KS, Derosiers MF, Tyas SL, Gross MD (2012) Blood folate is associated with asymptomatic or partially symptomatic Alzheimer's disease in the Nun study. J Alzheimers Dis 28, 637-645.
147. Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural
148. Durga J, van Boxtel MP, Schouten EG, Kok FJ, Jolles J, Katan MB, Verhoef P (2007) Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: A randomised, double blind, controlled trial. Lancet 369, 208-216. (Pubitemid 46107683)
149. Mattson MP (2003) Will caloric restriction and folate protect against AD and PD? Neurology 60, 690-695. (Pubitemid 36246090)
150. Kruman II, Mouton PR, Emokpae R Jr, Cutler RG, Mattson MP (2005) Folate deficiency inhibits proliferation of adult hippocampal progenitors. Neuroreport 16, 1055-1059. (Pubitemid 41017605)
151. Rabaneda LG, Carrasco M, Lopez-Toledano MA, Murillo-Carretero M, Ruiz FA, Estrada C, Castro C (2008) Homocysteine inhibits proliferation of neuronal precursors in the mouse adult brain by impairing the basic fibroblast growth factor signaling cascade and reducing extracellular regulated kinase 1/2-dependent cyclin E expression. FASEB J 22, 3823-3835.
152. Zhang XM, Huang GW, Tian ZH, Ren DL, Wilson JX (2009) Folate stimulates ERK1/2 phosphorylation and cell proliferation in fetal neural stem cells. Nutr Neurosci 12, 226-232.
153. Liu L, van Groen T, Kadish I, Tollefsbol TO (2009) DNA methylation impacts on learning and memory in aging. Neu-robiol Aging 30, 549-560.
154. Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J, Evans M, Mattson MP (2002) Folic acid deficiency and homocysteine impair DNA repairinhippocampal neurons and sensitize themtoamyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 22, 1752-1762. (Pubitemid 35386293)
155. Morris MC, Schneider JA, Tangney CC (2006) Thoughts on B-vitamins and dementia. J Alzheimers Dis 9, 429-433. (Pubitemid 44253358)
156. Das UN (2008) Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease-but how and why? Prostaglandins Leukot Essent Fatty Acids 78, 11-19.
157. Pita ML, Delgado MJ (2000) Folate administration increases n-3 polyunsaturated fatty acids in rat plasma and tissue lipids. Thromb Haemost 84, 420-423.
158. Bryan J, Calvaresi E, Hughes D (2002) Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages. J Nutr 132, 1345-1356. (Pubitemid 34606475)
159. Sommer BR, Hoff AL, Costa M (2003) Folic acid supplementation in dementia: A preliminary report. J Geriatr Psychiatry Neurol 16, 156-159. (Pubitemid 37409025)
160. Daviglus ML, Plassman BL, Pirzada A, Bell CC, Bowen PE, Burke JR, Connolly ES Jr, Dunbar-Jacob JM, Granieri EC, McGarry K, Patel D, Trevisan M, Williams JW. (2011) Risk factors and preventive interventions for Alzheimer disease: State of the science. Arch Neurol 68, 1185-1190.
161. Caudill MA (2010) Folate bioavailability: Implications for establishing dietary recommendations and optimizing status. Am J Clin Nutr 91, 1455S-1460S.
162. Zhao N, Zhong C, Wang Y, Zhao Y, Gong N, Zhou G, Xu T, Hong Z (2008) Impaired hippocampal neurogenesis is involved in cognitive dysfunction induced by thiamine deficiency at early pre-pathological lesion stage. Neurobiol Dis 29, 176-185.
163. Karuppagounder SS, Xu H, Shi Q, Chen LH, Pedrini S, Pechman D, Baker H, Beal MF, Gandy SE, Gibson GE (2009) Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model. Neurobiol Aging 30, 1587-1600.
164. Gibson GE, Sheu KF, Blass JP, Baker A, Carlson KC, Harding B, Perrino P (1988) Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch Neurol 45, 836-840.
165. Limoli CL, Giedzinski E, Baure J, Doctrow SR, Rola R, Fike JR (2006) Using superoxide dismutase/catalase mimetics to manipulate the redox environment of neural precursor cells. Radiat Prot Dosimetry 122, 228-236. (Pubitemid 47090456)
166. Molina JA, Jimenez-Jimenez FJ, Hernanz A, Fernandez-Vivancos E, Medina S, de Bustos F, Gomez-Escalonilla C, Sayed Y (2002) Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease. J Neural Transm 109, 1035-1044. (Pubitemid 34762342)
167. Rodriguez-Martin JL, Qizilbash N, Lopez-Arrieta JM. (2001) Thiamine for Alzheimer's disease. Cochrane Database Syst Rev, CD001498.
168. Crews FT, Nixon K (2009) Mechanisms of neurodegener-ation and regeneration in alcoholism. Alcohol Alcohol 44, 115-127.
169. Herrera DG, Yague AG, Johnsen-Soriano S, Bosch-Morell F, Collado-Morente L, Muriach M, Romero FJ, Garcia-Verdugo JM (2003) Selective impairment of hippocampal neurogenesis by chronic alcoholism: Protective effects of an antioxidant. Proc Natl Acad Sci USA 100, 7919-7924. (Pubitemid 36760070)
170. Anstey KJ, Mack HA, Cherbuin N (2009) Alcohol consumption as a risk factor for dementia and cognitive decline: Meta-analysis of prospective studies. Am J Geriatr Psychiatry 17, 542-555.
171. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3, 186-191. (Pubitemid 46825511)
172. Connelly PJ, Prentice NP, Cousland G, Bonham J (2008) A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease. Int J Geriatr Psychiatry 23, 155-160. (Pubitemid 351308495)
173. Taupin P (2006) Neurogenesis and Alzheimer's disease. Drug Target Insights 1, 1-4.
174. Taupin P (2009) Nootropic agents stimulate neurogenesis. Brain Cells, Inc.: WO2007104035. Expert Opin Ther Pat 19, 727-730.
175. Thaipisuttikul P, Galvin JE (2012) Use of medical foods and nutritional approaches in the treatment of Alzheimer's disease. Clin Pract (Lond) 9, 199-209.
176. Maioli S, Puerta E, Merino-Serrais P, Fusari L, Gil-Bea F, Rimondini R, Cedazo-Minguez A (2012) Combination of apolipoprotein E4 and high carbohydrate diet reduces hippocampal BDNF and arc levels and impairs memory in young mice. J Alzheimers Dis 32, 341-355.
177. Li G, Bien-Ly N, Andrews-Zwilling Y, Xu Q, Bernardo A, Ring K, Halabisky B, Deng C, Mahley RW, Huang Y (2009) GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. Cell Stem Cell 5, 634-645.
178. Kivipelto M, Rovio S, Ngandu T, Kareholt I, Eskelinen M, Winblad B, Hachinski V, Cedazo-Minguez A, Soininen H, Tuomilehto J, Nissinen A (2008) Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: A population-based study. J Cell Mol Med 12, 2762-2771.
179. Donovan MH, Yazdani U, Norris RD, Games D, German DC, Eisch AJ (2006) Decreased adult hippocampal neuro-genesis in the PDAPP mouse model of Alzheimer's disease. J Comp Neurol 495, 70-83. (Pubitemid 43238052)
180. Mirochnic S, Wolf S, Staufenbiel M, Kempermann G (2009) Age effects on the regulation of adult hippocampal neuroge-nesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease. Hippocampus 19, 1008-1018.
181. Lopez-Toledano MA, Shelanski ML (2007) Increased neu-rogenesis in young transgenic mice overexpressing human APP (Sw, Ind). J Alzheimers Dis 12, 229-240. (Pubitemid 350179250)
182. Jin K, Galvan V, Xie L, Mao XO, Gorostiza OF, Bre-desen DE, Greenberg DA (2004) Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw, Ind) mice. Proc Natl Acad Sci USA 101, 13363-13367. (Pubitemid 39209671)
183. Dong H, Goico B, Martin M, Csernansky CA, Bertchume A, Csernansky JG (2004) Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuro-science 127, 601-609. (Pubitemid 38993164)
184. Herring A, Ambree O, Tomm M, Habermann H, Sachser N, Paulus W, Keyvani K (2009) Environmental enrichment enhances cellular plasticity in transgenic mice with Alzheimer-like pathology. Exp Neurol 216, 184-192.
185. Haughey NJ, Nath A, Chan SL, Borchard AC, Rao MS, Mattson MP (2002) Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell home-ostasis, in models of Alzheimer's disease. J Neurochem 83, 1509-1524. (Pubitemid 35477489)
186. Morley JE (2002) The SAMP8 mouse: A model of Alzheimer disease? Biogerontology 3, 57-60. (Pubitemid 34284978)
187. Gang B, Yue C, Han N, Xue H, Li B, Sun L, Li X, Zhao Q (2011) Limited hippocampal neurogenesis in SAMP8 mouse model of Alzheimer's disease. Brain Res 1389, 183-193.
188. Zhang C, McNeil E, Dressler L, Siman R (2007) Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease. Exp Neurol 204, 77-87. (Pubitemid 46330258)
189. Gan L, Qiao S, Lan X, Chi L, Luo C, Lien L, Yan Liu Q, Liu R (2008) Neurogenic responses to amyloid-beta plaques in the brain of Alzheimer's disease-like transgenic (pPDGF-APPSw, Ind) mice. Neurobiol Dis 29, 71-80. (Pubitemid 350180484)
190. Kolecki R, Lafauci G, Rubenstein R, Mazur-Kolecka B, Kaczmarski W, Frackowiak J (2008) The effect of amyloidosis-beta and ageing on proliferation of neuronal progenitor cells in APP-transgenic mouse hippocampus and in culture. Acta Neuropathol 116, 419-424.
191. Yu Y, He J, Zhang Y, Luo H, Zhu S, Yang Y, Zhao T, Wu J, Huang Y, Kong J, Tan Q, Li XM (2009) Increased hippocam-pal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model. Hippocampus 19, 1247-1253.
192. Niidome T, Taniuchi N, Akaike A, Kihara T, Sugimoto H (2008) Differential regulation of neurogenesis in two neurogenic regions of APPswe/PS1dE9 transgenic mice. Neuroreport 19, 1361-1364.
193. Hamilton A, Holscher C (2012) The effect of ageing on neurogenesis and oxidative stress in the APP (swe)/PS1 (deltaE9) mouse model of Alzheimer's disease. Brain Res 1449, 83-93.
194. Taniuchi N, Niidome T, Goto Y, Akaike A, Kihara T, Sug-imoto H (2007) Decreased proliferation of hippocampal progenitor cells in APPswe/PS1dE9 transgenic mice. Neu-roreport 18, 1801-1805. (Pubitemid 350303755)
195. Demars M, Hu YS, Gadadhar A, Lazarov O (2010) Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice. J Neurosci Res 88, 2103-2117.
196. Rodriguez JJ, Jones VC, Tabuchi M, Allan SM, Knight EM, LaFerla FM, Oddo S, Verkhratsky A (2008) Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease. PLoS One 3, e2935.
197. Poirier R, Veltman I, Pflimlin MC, Knoflach F, Metzger F (2010) Enhanced dentate gyrus synaptic plasticity but reduced neurogenesis in a mouse model of amyloidosis. Neurobiol Dis 40, 386-393.
198. Ermini FV, Grathwohl S, Radde R, Yamaguchi M, Staufen-biel M, Palmer TD, Jucker M (2008) Neurogenesis and alterations of neural stem cells in mouse models of cerebral amyloidosis. Am J Pathol 172, 1520-1528. (Pubitemid 351793346)
199. Chevallier NL, Soriano S, Kang DE, Masliah E, Hu G, Koo EH (2005) Perturbed neurogenesis in the adult hippocampus associated with presenilin-1 A246E mutation. Am J Pathol 167, 151-159. (Pubitemid 40884778)
200. Wang R, Dineley KT, Sweatt JD, Zheng H (2004) Presenilin 1 familial Alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis. Neu-roscience 126, 305-312. (Pubitemid 38780806)
201. Wen PH, Hof PR, Chen X, Gluck K, Austin G, Younkin SG, Younkin LH, DeGasperi R, Gama Sosa MA, Robakis NK, Haroutunian V, Elder GA (2004) The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice. Exp Neurol 188, 224-237. (Pubitemid 38891583)
202. Wen PH, Shao X, Shao Z, Hof PR, Wisniewski T, Kelley K, Friedrich VL Jr, Ho L, Pasinetti GM, Shioi J, Robakis NK, Elder GA (2002) Overexpression of wild type but not an FAD mutant presenilin-1 promotes neurogenesis in the hippocampus of adult mice. Neurobiol Dis 10, 8-19. (Pubitemid 34757077)
203. Feng R, Rampon C, Tang YP, Shrom D, Jin J, Kyin M, Sopher B, Miller MW, Ware CB, Martin GM, Kim SH, Langdon RB, Sisodia SS, Tsien JZ (2001) Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces. Neuron 32, 911-926. (Pubitemid 34024850)
204. Chen Q, Nakajima A, Choi SH, Xiong X, Tang YP (2008) Loss of presenilin function causes Alzheimer's disease-like neurodegeneration in the mouse. J Neurosci Res 86, 1615-1625. (Pubitemid 351642455)
205. Levi O, Michaelson DM (2007) Environmental enrichment stimulates neurogenesis in apolipoprotein E3 and neuronal apoptosis in apolipoprotein E4 transgenic mice. J Neu-rochem 100, 202-210. (Pubitemid 46085849)
206. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J (2006) Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: A randomized double-blind trial. Arch Neurol 63, 1402-1408. (Pubitemid 44547551)
207. Xu Y, Ku B, Tie L, Yao H, Jiang W, Ma X, Li X (2006) Cur-cumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB. Brain Res 1122, 56-64. (Pubitemid 44708120)
208. Baum L, Lam CW, Cheung SK, Kwok T, Lui V, Tsoh J, Lam L, Leung V, Hui E, Ng C, Woo J, Chiu HF, Goggins WB, Zee BC, Cheng KF, Fong CY, Wong A, Mok H, Chow MS, Ho PC, Ip SP, Ho CS, Yu XW, Lai CY, Chan MH, Szeto S, Chan IH, Mok V (2008) Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 28, 110-113.
209. Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, Gylys KH, Badmaev V, Heath DD, Apostolova LG, Porter V, Vanek Z, Marshall GA, Hellemann G, Sugar C, Masterman DL, Montine TJ, Cummings JL, Cole GM (2012) Oral curcumin for Alzheimer's disease: Tolerabil-ity and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther 4, 43.
210. Park HR, Kong KH, Yu BP, Mattson MP, Lee J (2012) Resveratrol inhibits the proliferation of neural progenitor cells and hippocampal neurogenesis. J Biol Chem 287, 42588-42600.
211. Orgogozo JM, Dartigues JF, Lafont S, Letenneur L, Com-menges D, Salamon R, Renaud S, Breteler MB (1997) Wine consumption and dementia in the elderly: A prospective community study in the Bordeaux area. Rev Neurol (Paris) 153, 185-192. (Pubitemid 27262834)
212. Gower-Winter SD, Corniola RS, Morgan TJ Jr, Levenson CW (2013) Zinc deficiency regulates hippocampal gene expression and impairs neuronal differentiation. Nutr Neu-rosci 16, 174-182.
213. Corniola RS, Tassabehji NM, Hare J, Sharma G, Leven-son CW (2008) Zinc deficiency impairs neuronal precursor cell proliferation and induces apoptosis via p53-mediated mechanisms. Brain Res 1237, 52-61.
214. de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD (2012) Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial. Int J Geriatr Psychiatry 27, 592-600.
215. Douaud G, Refsum H, de Jager CA, Jacoby R, Nichols T, Smith SM, Smith AD (2013) Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci USA 110, 9523-9528.
216. He J, Nixon K, Shetty AK, Crews FT (2005) Chronic alcohol exposure reduces hippocampal neurogenesis and dendritic growth of newborn neurons. Eur J Neurosci 21, 2711-2720. (Pubitemid 40835114)
217. Nixon K, Crews FT (2002) Binge ethanol exposure decreases neurogenesis in adult rat hippocampus. J Neu-rochem 83, 1087-1093. (Pubitemid 35397118)